Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313


Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study.

Kadono Y, Konaka H, Izumi K, Anai S, Fujimoto K, Ishibashi K, Kawai N, Kato T, Iba A, Masumori N, Yoshimura K, Mizokami A.

Contemp Clin Trials Commun. 2019 Jun 26;15:100403. doi: 10.1016/j.conctc.2019.100403. eCollection 2019 Sep.


A Case of Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.

Sakaguchi R, Fujikawa K, Okamoto M, Matsuo E, Matsumoto K, Uchida T, Shin-Ya K, Nakashima M, Mizokami A, Kawakami A.

Intern Med. 2019 Jul 10. doi: 10.2169/internalmedicine.2995-19. [Epub ahead of print]

Free Article

Metastatic urachal cancer treated effectively with gemcitabine/cisplatin combination chemotherapy and radiotherapy: A case report.

Yaegashi H, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A.

Mol Clin Oncol. 2019 Aug;11(2):139-142. doi: 10.3892/mco.2019.1865. Epub 2019 May 22.


A case of mesh erosion in the ureter eight years after a tension-free vaginal mesh surgery.

Nakagawa T, Kawaguchi S, Mizokami A.

Int Urogynecol J. 2019 Jun 26. doi: 10.1007/s00192-019-04028-2. [Epub ahead of print] No abstract available.


Reiter's syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases.

Nakagawa T, Shigehara K, Naito R, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Kitagawa Y, Izumi K, Kadono Y, Mizokami A.

Int Cancer Conf J. 2018 Aug 21;7(4):148-151. doi: 10.1007/s13691-018-0342-1. eCollection 2018 Oct.


Phospholipase C-related catalytically inactive protein: A novel signaling molecule for modulating fat metabolism and energy expenditure.

Kanematsu T, Oue K, Okumura T, Harada K, Yamawaki Y, Asano S, Mizokami A, Irifune M, Hirata M.

J Oral Biosci. 2019 Jun;61(2):65-72. doi: 10.1016/j.job.2019.04.002. Epub 2019 May 15. Review.


Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital.

Nakashima K, Makino T, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Matsuo S, Mizokami A.

Anticancer Res. 2019 May;39(5):2607-2614. doi: 10.21873/anticanres.13384.


Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.

Kadomoto S, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Nakajima K, Mizokami A.

Anticancer Res. 2019 May;39(5):2553-2559. doi: 10.21873/anticanres.13377.


Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review.

Kadomoto S, Shigehara K, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Mizokami A.

World J Mens Health. 2019 May 2. doi: 10.5534/wjmh.180130. [Epub ahead of print]


Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced Cancer.

Takezawa Y, Izumi K, Kamijima T, Machioka K, Shima T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Seto C, Mizokami A.

In Vivo. 2019 May-Jun;33(3):877-880. doi: 10.21873/invivo.11553.


Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.

Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Mizokami A, Maeda T, Kawakami A.

Int J Rheum Dis. 2019 May;22(5):842-851. doi: 10.1111/1756-185X.13543. Epub 2019 Mar 18.


Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.

Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14.


Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells.

Izumi K, Mizokami A.

J Clin Med. 2019 Mar 13;8(3). pii: E354. doi: 10.3390/jcm8030354. Review.


Gonadal function and testicular histology in males with Prader-Willi syndrome.

Matsuyama S, Matsui F, Matsuoka K, Iijima M, Takeuchi M, Ida S, Matsumoto F, Mizokami A.

Endocrinol Diabetes Metab. 2018 Oct 30;2(1):e00049. doi: 10.1002/edm2.49. eCollection 2019 Jan.


Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy.

Shimura Y, Izumi K, Itai S, Iwamoto H, Yaegashi H, Suga Y, Shimada T, Mizokami A, Sai Y.

In Vivo. 2019 Mar-Apr;33(2):643-647. doi: 10.21873/invivo.11522.


A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation.

Kawaguchi S, Kadono Y, Nohara T, Kato Y, Nakagawa T, Urata S, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Urol Int. 2019 Feb 20:1-3. doi: 10.1159/000497108. [Epub ahead of print]


Novel Prevention Procedure for Inguinal Hernia after Robot-Assisted Radical Prostatectomy: Results from a Prospective Randomized Trial.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

J Endourol. 2019 Apr;33(4):302-308. doi: 10.1089/end.2018.0898. Epub 2019 Mar 20.


Characteristics of late-onset spondyloarthritis in Japan: A retrospective cohort study.

Endo Y, Fujikawa K, Koga T, Mizokami A, Mine M, Tsukada T, Uetani M, Kawakami A.

Medicine (Baltimore). 2019 Feb;98(7):e14431. doi: 10.1097/MD.0000000000014431.


Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.

Nakagawa R, Shigehara K, Aoyama S, Urata S, Ofude M, Miyagi T, Nakashima T, Izumi K, Mizokami A.

J Infect Chemother. 2019 May;25(5):337-340. doi: 10.1016/j.jiac.2019.01.004. Epub 2019 Feb 2.


The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study.

Kato Y, Shigehara K, Nakashima K, Iijima M, Kawagushi S, Nohara T, Izumi K, Kadono Y, Konaka H, Namiki M, Mizokami A.

Aging Male. 2019 Jan 16:1-6. doi: 10.1080/13685538.2018.1550060. [Epub ahead of print]


Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer.

Makino T, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Kumano T, Mizokami A.

Anticancer Res. 2019 Jan;39(1):477-486. doi: 10.21873/anticanres.13137.


High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.

Yaegashi H, Izumi K, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Mizokami A.

Anticancer Res. 2019 Jan;39(1):375-380. doi: 10.21873/anticanres.13122.


Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.

Izumi K, Iwamoto H, Yaegashi H, Shigehara K, Nohara T, Kadono Y, Mizokami A.

In Vivo. 2019 Jan-Feb;33(1):167-172. doi: 10.21873/invivo.11454.


Evaluating urinary incontinence before and after radical prostatectomy using the international consultation on incontinence questionnaire-short form.

Machioka K, Kadono Y, Naito R, Nakashima K, Iijima M, Kawaguchi S, Shigehara K, Nohara T, Izumi K, Mizokami A.

Neurourol Urodyn. 2019 Feb;38(2):726-733. doi: 10.1002/nau.23907. Epub 2018 Dec 21.


Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.

Iwamoto H, Izumi K, Natsagdorj A, Naito R, Makino T, Kadomoto S, Hiratsuka K, Shigehara K, Kadono Y, Narimoto K, Saito Y, Nakagawa-Goto K, Mizokami A.

Prostate. 2019 Apr;79(5):468-479. doi: 10.1002/pros.23753. Epub 2018 Dec 19.


Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300.

Otani T, Matsuda M, Mizokami A, Kitagawa N, Takeuchi H, Jimi E, Inai T, Hirata M.

Cell Death Dis. 2018 Dec 13;9(12):1194. doi: 10.1038/s41419-018-1257-7.


Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 - 100 ng / mL.

Iwamoto H, Izumi K, Kadono Y, Mizokami A.

Int Braz J Urol. 2019 Jan-Feb;45(1):61-67. doi: 10.1590/S1677-5538.IBJU.2018.0143.


CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.

Natsagdorj A, Izumi K, Hiratsuka K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Shigehara K, Kadono Y, Lin WJ, Maolake A, Mizokami A.

Cancer Sci. 2019 Jan;110(1):279-288. doi: 10.1111/cas.13876. Epub 2018 Dec 7.


Etiological role of human papillomavirus infection in the development of penile cancer.

Sakamoto J, Shigehara K, Nakashima K, Kawaguchi S, Nakashima T, Shimamura M, Yasuda M, Kato T, Hasegawa T, Kobori Y, Okada H, Deguchi T, Izumi K, Kadono Y, Mizokami A.

Int J Infect Dis. 2019 Jan;78:148-154. doi: 10.1016/j.ijid.2018.11.003. Epub 2018 Nov 10.


Predictors of persistent stress urinary incontinence after transvaginal mesh repair.

Kawaguchi S, Narimoto K, Urata S, Takeyama M, Kadono Y, Mizokami A.

BMC Womens Health. 2018 Oct 25;18(1):174. doi: 10.1186/s12905-018-0667-0.


5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.

Saito Y, Mizokami A, Tsurimoto H, Izumi K, Goto M, Nakagawa-Goto K.

Eur J Med Chem. 2018 Sep 5;157:1143-1152. doi: 10.1016/j.ejmech.2018.08.069. Epub 2018 Aug 28.


Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.

Shigehara K, Konaka H, Kato Y, Iijima M, Nakashima K, Kawaguchi S, Nohara T, Izumi K, Namiki M, Mizokami A.

Int J Impot Res. 2019 Jan;31(1):25-30. doi: 10.1038/s41443-018-0065-z. Epub 2018 Aug 22.


Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Makino T, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Andrology. 2018 Nov;6(6):903-908. doi: 10.1111/andr.12517. Epub 2018 Jul 2.


Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor.

Iwamoto H, Izumi K, Natsagdorj A, Makino T, Nohara T, Shigehara K, Kadono Y, Mizokami A.

In Vivo. 2018 Jul-Aug;32(4):899-903. doi: 10.21873/invivo.11326.


Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer.

Mori H, Nakajima K, Kadomoto S, Mizokami A, Ikeda H, Wakabayashi H, Kinuya S.

Intern Med. 2018 Nov 1;57(21):3123-3128. doi: 10.2169/internalmedicine.0630-17. Epub 2018 Jun 6.


Risk factors for human papillomavirus detection in urine samples of heterosexual men visiting urological clinics in Japan.

Nakashima K, Shigehara K, Kitamura T, Yaegashi H, Shimamura M, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.

J Infect Chemother. 2018 Sep;24(9):713-717. doi: 10.1016/j.jiac.2018.04.011. Epub 2018 May 11.


Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation.

Ishii K, Sasaki T, Iguchi K, Kajiwara S, Kato M, Kanda H, Hirokawa Y, Arima K, Mizokami A, Sugimura Y.

Prostate. 2018 Aug;78(11):849-856. doi: 10.1002/pros.23643. Epub 2018 Apr 29.


Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines.

Machioka K, Izumi K, Kadono Y, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Keller ET, Zhang J, Mizokami A.

Oncotarget. 2018 Mar 5;9(22):16185-16196. doi: 10.18632/oncotarget.24609. eCollection 2018 Mar 23.


Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.

Kawashiri SY, Nishino A, Igawa T, Takatani A, Shimizu T, Umeda M, Fukui S, Okada A, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakashima M, Mizokami A, Matsuoka N, Migita K, Ogawa F, Ikeda S, Maemura K, Nakamura H, Origuchi T, Maeda T, Kawakami A.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):102-108. Epub 2018 Apr 12.


Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.

Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.

Int J Urol. 2018 May;25(5):492-499. doi: 10.1111/iju.13556. Epub 2018 Apr 6.


Significance of Perioperative Chemotherapy in Squamous Cell Carcinoma of the Upper and Lower Urinary Tract.

Makino T, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Naito R, Kadono Y, Mizokami A.

Anticancer Res. 2018 Apr;38(4):2241-2245.


Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.

Takezawa Y, Izumi K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Kadono Y, Keller ET, Zhang J, Mizokami A.

Anticancer Res. 2018 Apr;38(4):2045-2055.


Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.

Maolake A, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Makino T, Naito R, Shigehara K, Kadono Y, Hiratsuka K, Wufuer G, Nastiuk KL, Mizokami A.

Cancer Sci. 2018 May;109(5):1524-1531. doi: 10.1111/cas.13586. Epub 2018 Apr 29.


Overexpression of p54nrb/NONO induces differential EPHA6 splicing and contributes to castration-resistant prostate cancer growth.

Yamamoto R, Osawa T, Sasaki Y, Yamamoto S, Anai M, Izumi K, Matsumura Y, Sakai J, Aburatani H, Mizokami A, Kodama T, Tanaka T.

Oncotarget. 2018 Jan 8;9(12):10510-10524. doi: 10.18632/oncotarget.24063. eCollection 2018 Feb 13.


Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathway.

Shi J, Wang L, Zou C, Xia Y, Qin S, Keller E, Mizokami A, Zhang J, Lu Y.

Oncotarget. 2018 Jan 9;9(10):9206-9218. doi: 10.18632/oncotarget.24104. eCollection 2018 Feb 6.


Investigating the mechanism underlying urinary continence recovery after radical prostatectomy: effectiveness of a longer urethral stump to prevent urinary incontinence.

Kadono Y, Nohara T, Kawaguchi S, Naito R, Urata S, Nakashima K, Iijima M, Shigehara K, Izumi K, Gabata T, Mizokami A.

BJU Int. 2018 Sep;122(3):456-462. doi: 10.1111/bju.14181. Epub 2018 Mar 22.


Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.

Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H.

Arthritis Rheumatol. 2018 Jul;70(7):1014-1021. doi: 10.1002/art.40461. Epub 2018 May 25.


C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment.

Urata S, Izumi K, Hiratsuka K, Maolake A, Natsagdorj A, Shigehara K, Iwamoto H, Kadomoto S, Makino T, Naito R, Kadono Y, Lin WJ, Wufuer G, Narimoto K, Mizokami A.

Cancer Sci. 2018 Mar;109(3):724-731. doi: 10.1111/cas.13494. Epub 2018 Feb 14.


Editorial Comment to Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement.

Shigehara K, Mizokami A.

Int J Urol. 2018 Jan;25(1):74-75. doi: 10.1111/iju.13477. Epub 2017 Oct 23. No abstract available.

Supplemental Content

Loading ...
Support Center